Abacus Global Management (ABX) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
11 May, 2026Executive summary
Raised full-year 2026 adjusted net income guidance to $100M–$106M ($1.00–$1.05 adjusted EPS), reflecting strong business momentum and visibility into capital inflows, with Q2 guidance of $24M–$26M.
Q1 2026 revenue grew 34.6%–35% year-over-year to $59.4M, driven by Life Solutions and asset management, with adjusted net income up 17% to $20.1M and adjusted EBITDA up 33% to $32.7M (55% margin).
Operating cash flow improved to $91.7M from a negative $61.6M in Q1 2025, demonstrating strong cash generation.
Significant capital inflows into longevity funds ($288M–$378M in Q1), with AUM nearly quadrupling year-over-year to ~$1B and gross AUM reaching $3.6B.
Returned 100% of capital to LMA Income II fund investors at term end, reducing debt by ~$76M, with high reinvestment rates and improved leverage ratios.
Financial highlights
Q1 2026 total revenue was $59.4M, up 34.6%–35% YoY, with Life Solutions contributing $50.6M and asset management fees $8.5M.
Adjusted net income rose 16.6%–17% to $20.1M; adjusted EBITDA increased 33% to $32.7M (55% margin).
GAAP net income attributable was $7.3M ($0.07 per diluted share), up 56%–59% year-over-year.
Operating cash flow was $91.7M, a $153M swing from -$61.6M in Q1 2025.
Balance sheet policy assets at $392.8M; cash of $37.2M; long-term debt reduced to ~$328M–$330M.
Outlook and guidance
Full-year 2026 adjusted net income guidance raised to $100M–$106M; adjusted EPS $1.00–$1.05.
Q2 2026 adjusted net income expected at $24M–$26M ($0.24–$0.26 adjusted EPS).
Back half of the year expected to be strongest, following historical seasonality.
Targeting a second securitization in late Q2 or early Q3, which could be incremental to $500M first-half inflow expectation.
Latest events from Abacus Global Management
- Longevity, AI, and private markets are transforming wealth management and investment priorities.ABX
29th Annual Global Conference9 May 2026 - Outstanding shares corrected to 96,138,555; no impact on proposals or board recommendations.ABX
Proxy filing29 Apr 2026 - Shareholders will vote on director elections, auditor ratification, and a new equity plan.ABX
Proxy filing21 Apr 2026 - Investing in longevity market assets provides uncorrelated, investment-grade returns in a regulated space.ABX
Corporate presentation30 Mar 2026 - Record 2025 revenue and earnings growth, with robust 2026 outlook and new capital returns.ABX
Q4 202512 Mar 2026 - Record 2024 growth and acquisitions set stage for 51–68% adjusted net income rise in 2025.ABX
Q4 202412 Mar 2026 - Expanding via acquisitions and data services, driving growth in the uncorrelated life settlements market.ABX
17th Annual LD Micro Main Event Conference3 Feb 2026 - Q2 2024 revenue doubled to $29.1M, with strong earnings and major acquisitions announced.ABX
Q2 20241 Feb 2026 - Q3 revenue up 33% and adjusted EBITDA up 54%, with $2.6B in AUM from acquisitions pending.ABX
Q3 202415 Jan 2026